Accessibility
Animation
Accessibility

Poster

Serum vedolizumab and corresponding anti-vedolizumab antibody: Analysis of over 6500 patient results using lab developed chemiluminescent immunoassays (ECLIA)

December 12, 2019

Published in: AIBD (Advances in Inflammatory Bowel Diseases)